Literature DB >> 15616172

Prefrontal cortical dysfunction in abstinent cocaine abusers.

Karen Bolla1, Monique Ernst, Kent Kiehl, Maria Mouratidis, Dana Eldreth, Carlo Contoreggi, John Matochik, Varughese Kurian, Jean Cadet, Alane Kimes, Frank Funderburk, Edythe London.   

Abstract

The anterior cingulate cortex (ACC) and lateral prefrontal (LPFC) cortex are brain regions important to executive cognitive functions (ECF). We determined ACC and LPFC function in 23-day abstinent cocaine abusers using positron emission tomography (PET H(2)(15)O) during performance of a modified version of the Stroop Task. Cocaine abusers showed less activation than non-drug-using comparison subjects in the left ACC and the right LPFC and greater activation in the right ACC. Average amount of cocaine used per week was negatively correlated with activity in the rostral ACC and right LPFC. Disruption of ECF in substance abusers could interfere with attempts to stop drug use and undermine treatment. Since impairment in ECF may be a common feature of various neuropsychiatric disorders, these findings have applicability beyond the neurobiology of addiction.

Entities:  

Mesh:

Year:  2004        PMID: 15616172      PMCID: PMC2771441          DOI: 10.1176/jnp.16.4.456

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  32 in total

1.  Neurovascular deficits in cocaine abusers.

Authors:  R I Herning; D E King; W E Better; J L Cadet
Journal:  Neuropsychopharmacology       Date:  1999-07       Impact factor: 7.853

2.  Differential effects of cocaine and cocaine alcohol on neurocognitive performance.

Authors:  K I Bolla; F R Funderburk; J L Cadet
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

3.  A unified statistical approach for determining significant signals in images of cerebral activation.

Authors:  K J Worsley; S Marrett; P Neelin; A C Vandal; K J Friston; A C Evans
Journal:  Hum Brain Mapp       Date:  1996       Impact factor: 5.038

4.  Cognitive frontal lobe dysfunction in obsessive-compulsive disorder.

Authors:  K Schmidtke; A Schorb; G Winkelmann; F Hohagen
Journal:  Biol Psychiatry       Date:  1998-05-01       Impact factor: 13.382

5.  The variability of human, BOLD hemodynamic responses.

Authors:  G K Aguirre; E Zarahn; M D'esposito
Journal:  Neuroimage       Date:  1998-11       Impact factor: 6.556

Review 6.  The neuropsychiatry of chronic cocaine abuse.

Authors:  K I Bolla; J L Cadet; E D London
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1998       Impact factor: 2.198

7.  Anterior cingulate cortex, error detection, and the online monitoring of performance.

Authors:  C S Carter; T S Braver; D M Barch; M M Botvinick; D Noll; J D Cohen
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

8.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

9.  Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study.

Authors:  X Liu; J A Matochik; J L Cadet; E D London
Journal:  Neuropsychopharmacology       Date:  1998-04       Impact factor: 7.853

Review 10.  Positron emission tomography in psychiatric and neuropsychiatric disorders.

Authors:  R J Dolan; K J Friston
Journal:  Semin Neurol       Date:  1989-12       Impact factor: 3.420

View more
  120 in total

1.  Neuropsychological effects associated with recreational cocaine use.

Authors:  Kirstie Soar; Colette Mason; Anita Potton; Lynne Dawkins
Journal:  Psychopharmacology (Berl)       Date:  2012-02-29       Impact factor: 4.530

Review 2.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

3.  P300 and the stroop effect in overweight minority adolescents.

Authors:  Lance O Bauer; Richard F Kaplan; Victor M Hesselbrock
Journal:  Neuropsychobiology       Date:  2010-03-18       Impact factor: 2.328

4.  Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals.

Authors:  Ryan P Bell; John J Foxe; Jay Nierenberg; Matthew J Hoptman; Hugh Garavan
Journal:  Drug Alcohol Depend       Date:  2010-11-13       Impact factor: 4.492

5.  Bayesian neural adjustment of inhibitory control predicts emergence of problem stimulant use.

Authors:  Katia M Harlé; Jennifer L Stewart; Shunan Zhang; Susan F Tapert; Angela J Yu; Martin P Paulus
Journal:  Brain       Date:  2015-09-03       Impact factor: 13.501

6.  Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence.

Authors:  D Tomasi; R Z Goldstein; F Telang; T Maloney; N Alia-Klein; E C Caparelli; N D Volkow
Journal:  Brain Res       Date:  2007-08-10       Impact factor: 3.252

Review 7.  PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.

Authors:  Robert W Gould; Angela N Duke; Michael A Nader
Journal:  Neuropharmacology       Date:  2013-02-28       Impact factor: 5.250

8.  Smoking reduces conflict-related anterior cingulate activity in abstinent cigarette smokers performing a Stroop task.

Authors:  Allen Azizian; Liam J Nestor; Doris Payer; John R Monterosso; Arthur L Brody; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2009-11-11       Impact factor: 7.853

Review 9.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Prior chronic cocaine exposure in mice induces persistent alterations in cognitive function.

Authors:  Dilja D Krueger; Jessica L Howell; Heyman Oo; Peter Olausson; Jane R Taylor; Angus C Nairn
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.